NovaBay Pharmaceuticals Signs Agreement with Nation’s Second Largest Independent Optometry Group, ALLDocs

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE MKT:NBY), a biopharmaceutical company focusing on commercializing and developing non-antibiotic antimicrobial products for the global eye care market, today announced that the company’s prescription daily eyelid and lash hygiene product Avenova™ will be marketed through ALLDocs Optometry Group, making the product available to the group’s optometrists. ALLDocs, also known as The Association of LensCrafters Leaseholding Doc